How to Indirectly Invest in Synthetic Genomics Stock

March 29. 2017. 5 mins read

One of the biggest themes we see here at Nanalyze is a strong interest from retail investors to invest in exciting emerging technology startups. Take a look at any exciting startup like Synthetic Genomics and you will see the most popular searches are “synthetic genomics stock” or “synthetic genomics ticker”. While we’ve given you at least several ways you can buy pre-IPO shares, it’s rare to see an investment opportunity that involves a leading emerging technology startup.

Which emerging technology startups are “leading”? One way to figure that out is to look at who is running the startup, who is backing it, who is working with them, and the amount of funding they’ve taken in. In all sincerity, we would consider Synthetic Genomics (SGI) to be the most exciting synthetic biology startup out there. We’re going to tell you why, and we’re going to tell you how you can get exposure to their shares.

Synthetic Genomics

Click for company website

This isn’t the first time we’ve written about Synthetic Genomics. We first wrote about the co-founder, Craig Venter, who has a pedigree that is difficult to put in words – few words that is. He was one of the first people to sequence the genome and

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.